Abstract
Extracorporeal membrane oxygenation (ECMO), modified cardiopulmonary bypass, is a life-saving procedure for neonates with reversible cardiorespiratory failure. This complex, invasive therapy requires a skilled multidisciplinary team to achieve optimal results. Ready access to blood products is critical and transfusion services are vital in the care of a patient receiving ECMO. Blood products (red blood cells, platelets, and plasma) are a constant requirement during this form of ongoing massive transfusion in the neonatal patient. Complications, such as hemorrhage and clotting in the circuit, must be monitored through the ECMO course via tests assessing the integrity of the coagulation cascade as well as heparin therapy. Over the decades, intact survival rates continue to improve for neonates.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
AABB, Clinical Transfusion Medicine Committee. AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections. Transfusion. 2016;56(6 Pt 2):1581–7.
Anderson HL 3rd, Snedecor S. Multicenter comparison of conventional venoarterial access versus venovenous double-lumen catheter access in newborn infants undergoing extracorporeal membrane oxygenation. J Pediatr Surg. 1993;28(4):530–4.
Ang AL, Teo D. Blood transfusion requirements and independent predictors of increased transfusion requirements among adult patients on extracorporeal membrane oxygenation: a single centre experience. Vox Sang. 2009;96(1):34–43.
Annich G, Lynch WR, MacLaren G, Wilson JM, Barlett RH, editors. ECMO extracorporeal cardiopulmonary support in critical care. 4th ed. Ann Arbor: ELSO; 2012.
Baker-Groberg SM, Lattimore S, et al. Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost. 2016;14(4):815–27.
Barrett CS, Jaggers JJ, et al. Outcomes of neonates undergoing extracorporeal membrane oxygenation support using centrifugal versus roller blood pumps. Ann Thorac Surg. 2012;94(5):1635–41.
Bartlett RH, Roloff DW, et al. Extracorporeal life support: the University of Michigan experience. JAMA. 2000;283(7):904–8.
Bembea MM, Annich G, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey. Pediatr Crit Care Med. 2013;14(2):e77–84.
Bembea MM, Schwartz JM, et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J. 2013;59(1):63–8.
Bennett CC, Johnson A, UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet. 2001;357(9262):1094–6.
Bjerke HS, Kelly Jr RE, et al. Decreasing transfusion exposure risk during extracorporeal membrane oxygenation (ECMO). Transfus Med. 1992;2(1):43–9.
Boodram S, Evans E. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review. J Extra Corpor Technol. 2008;40(1):27–42.
Bui JD, Despotis GD, et al. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002;124(4):852–4.
Chevuru SC, Sola MC, Florida Collaborative Neonatology Research Group. Multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation. Pediatrics. 2002;109(6):e89.
Diab YA, Wong EC, Luban NL. Massive transfusion in children and neonates. Br J Haematol. 2013;161(1):15–26.
Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003;349(13):1205–6.
Downard CD, Betit P, et al. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg. 2003;38(8):1212–6.
Durandy Y. The impact of vacuum-assisted venous drainage and miniaturized bypass circuits on blood transfusion in pediatric cardiac surgery. ASAIO J. 2009;55(1):117–20.
ELSO. ELSO Anticoagulation Guidelines. 2016. Retrieved from elso.org: https://www.elso.org/portals/0/files/elsoanticoagulationguideline8-2014-table-contents.pdf.
Ferrer-Marin F, Stanworth S, et al. Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion. 2013;53(11):2814–21.
Fiser RT, Irby K, et al. RBC transfusion in pediatric patients supported with extracorporeal membrane oxygenation: is there an impact on tissue oxygenation? Pediatr Crit Care Med. 2014;15(9):806–13.
Annich GM. Extracorporeal life support: the precarious balance of hemostasis. J Thromb Haemost. 2015;13 Suppl 1:S336–42.
Hardart GE, Fackler JC. Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation. J Pediatr. 1999;134(2):156–9.
Henríquez-Henríquez M, Kattan J, et al. Blood component usage during extracorporeal membrane oxygenation: experience in 98 patients at a Latin-American tertiary hospital. Int J Artif Organs. 2014;37(3):233–40.
Hervey-Jumper SL, Annich GM. Neurological complications of extracorporeal membrane oxygenation in children. J Neurosurg Pediatr. 2011;7(4):338–44.
Jackson HT, Oyetunji TA, et al. The impact of leukoreduced red blood cell transfusion on mortality of neonates undergoing extracorporeal membrane oxygenation. J Surg Res. 2014;192(1):6–11.
Karimova A, Brown K, et al. Neonatal extracorporeal membrane oxygenation: practice patterns and predictors of outcome in the UK. Arch Dis Child Fetal Neonatal Ed. 2009;94(2):F129–32.
Khaja WA, Bilen O, et al. Evaluation of heparin assay for coagulation management in newborns undergoing ECMO. Am J Clin Pathol. 2010;134(6):950–4.
Khoshbin E, Westrope C, et al. Performance of polymethyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: a comparison with silicone membrane oxygenators. Perfusion. 2005;20(3):129–34.
Kipps AK, Wypij D, et al. Blood transfusion is associated with prolonged duration of mechanical ventilation in infants undergoing reparative cardiac surgery. Pediatr Crit Care Med. 2011;12(1):52–6.
Krisa VM, Kevin L, Peek G, Joseph Z, editors. ECMO extracorporeal cardiopulmonary support in critical care. 3rd ed. Ann Arbor: ELSO; 2005.
Kulat B, Zingle N. Optimizing circuit design using a remote-mounted perfusion system. J Extra Corpor Technol. 2009;41(1):28–31.
Lequier L, Horton SB, et al. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S7–12.
Li G, Rachmale S, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion. 2011;51(2):338–43.
Liveris A, Bello RA, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014;15(2):e72–9.
Madar J, Richmond S. Role of extracorporeal membrane oxygenation. Lancet. 1996;348(9030):823–4.
Masalunga C, Cruz M, et al. Increased hemolysis from saline pre-washing RBCs or centrifugal pumps in neonatal ECMO. J Perinatol. 2007;27(6):380–4.
McCoy-Pardington D, Judd WJ, et al. Blood use during extracorporeal membrane oxygenation. Transfusion. 1990;30(4):307–9.
Minifee PK, et al. Decreasing blood donor exposure in neonates on extracorporeal membrane oxygenation. J Pediatr Surg. 1990;25(1):38–42.
Mok YH, Lee J. Neonatal extracorporeal membrane oxygenation: update on management strategies and long-term outcomes. Adv Neonatal Care. 2016;16(1):26–36.
Nankervis CA, Preston TJ, et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J. 2007;53(1):111–4.
Niebler RA, Christensen M, et al. Antithrombin replacement during extracorporeal membrane oxygenation. Artif Organs. 2011;35(11):1024–8.
Luban NL. Neonatal red blood cell transfusions. Vox Sang. 2004;87 Suppl 2:184–8.
Ortolano GA, Aldea GS, et al. A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects. Perfusion. 2002;17(Suppl):53–62.
Osiovich HC, Peliowski A, et al. The Edmonton experience with venovenous extracorporeal membrane oxygenation. J Pediatr Surg. 1998;33(12):1749–52.
Paden ML, Paden ML, Rycus PL, Thiagarajan PR, ELSO Registry. Update and outcomes in extracorporeal life support. Semin Perinatol. 2014;38(2):65–70.
Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52 Suppl 1:65S–79.
Perry R, Stein J, et al. Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation. J Pediatr Surg. 2013;48(9):1837–42.
Polito A, Barrett CS, et al. Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med. 2013;39(9):1594–601.
Qureshi FG, Jackson HT, et al. The changing population of the United States and use of extracorporeal membrane oxygenation. J Surg Res. 2013;184(1):572–6.
Rosenberg EM, Chambers LA, et al. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation. Pediatrics. 1994;94(3):341–6.
Salvin JW, Scheurer MA, et al. Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg. 2011;91(1):204–10.
Smith A, Hardison D, et al. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013;28(1):54–60.
Smith KM, McMullan DM, et al. Is age at initiation of extracorporeal life support associated with mortality and intraventricular hemorrhage in neonates with respiratory failure? J Perinatol. 2014;34(5):386–91.
Sulkowski JP, Preston TJ, et al. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation. J Extra Corpor Technol. 2014;46(1):69–76.
Syburra T, Lachat M, et al. Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation. Ann Thorac Surg. 2010;89(5):1643–5.
Urlesberger B, Zobel G, et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr. 1996;129(2):264–8.
Usher R, Shephard M, Lind J. The blood volume of the newborn infant and placental transfusion. Acta Paediatr. 1963;52:497–512.
Velik-Salchner C, Sergi C. Use of recombinant factor VIIa (Novoseven) in combination with other coagulation products led to a thrombotic occlusion of the truncus brachiocephalicus in a neonate supported by extracorporeal membrane oxygenation. Anesth Analg. 2005;101(3):924.
Vlaar AP, Binnekade JM, et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case–control study. Crit Care Med. 2010;38(3):771–8.
Wylie MC, Graham DA, et al. Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol. 2010;31(10):1049–56.
Yuan S, Tsukahara E, et al. How we provide transfusion support for neonatal and pediatric patients on extracorporeal membrane oxygenation. Transfusion. 2013;53(6):1157–65.
Zavadil DP, Stammers AH, et al. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol. 1998;30(2):83–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nawab, U., Williams, S.B. (2017). Transfusion Considerations for Neonatal Extracorporeal Membrane Oxygenation (ECMO). In: Sesok-Pizzini, D. (eds) Neonatal Transfusion Practices. Springer, Cham. https://doi.org/10.1007/978-3-319-42764-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-42764-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42762-1
Online ISBN: 978-3-319-42764-5
eBook Packages: MedicineMedicine (R0)